Compound information
- Natural Products
- ZC2393230
- Molecular Formula
- C21H26N2O4S
- Molecular Weight
- 402.161328312 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-phenylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C21H26N2O4S/c1-21(2,3)27-20(24)22-13-15-23(16-14-22)28(25,26)19-11-9-18(10-12-19)17-7-5-4-6-8-17/h4-12H,13-16H2,1-3H3
- InChI Key
- ZGUNQUJEAHVNCA-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccc(-c3ccccc3)cc2)CC1
- Source
- ZINC000044606434
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 4.045 |
LogS | -5.681 | LogD | 4.355 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.044 | Pgp substrate | 0.56 |
HIA | 0.969 | F20 % | 0.994 |
F30 % | 0.97 | Caco-2 | -4.466 |
MDCK | -4.853 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.101 | PPB | 92.539 |
VD | 1.548 | Fu | 1.194 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.409 | CYP1A2 substrate | 0.468 |
CYP2A6 substrate | 0.514 | CYP2B6 substrate | 0.74 |
CYP2C19 inhibitor | 0.86 | CYP2C19 substrate | 0.85 |
CYP2C8 substrate | 0.619 | CYP2C9 inhibitor | 0.759 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.92 | CYP2E1 substrate | 0.929 |
CYP3A4 inhibitor | 0.171 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.134 | CL | 6.09 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.968 | Hepatotoxicity | 0.903 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.229 |
FDAMDD | 0.095 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.89 | Eye Corrosion | 0.002 |
Eye Irritation | 0.023 | Respiratory Toxicity | 0.079 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.008 | IGC50 | 4.472 |
LC50FM | 3.203 | LC50DM | 2.193 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.221 | NR-AR-LBD | 0.34 |
NR-AhR | 0.086 | NR-Aromatase | 0.671 |
NR-ER | 0.354 | NR-ER-LBD | 0.531 |
NR-PPAR-gamma | 0.213 | SR-ARE | 0.822 |
SR-ATAD5 | 0.429 | SR-HSE | 0.106 |
SR-MMP | 0.093 | SR-p53 | 0.029 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.